Breaking News

Piramal Pharma Lists on Stock Exchanges Following Demerger

Completes demerger process, in line with objective to transform the group from a multi-sector conglomerate into two separate sector-focused listed entities.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Piramal Pharma Limited (PPL) has listed on the Indian stock exchanges, Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).    In June 2020, PPL signed an agreement with The Carlyle Group Inc. to invest growth equity capital for a 20% stake in Piramal Pharma Ltd. Accordingly, the pharmaceuticals business was vertically demerged from Piramal Enterprises Limited (PEL). In October 2021, the Board of Directors of PEL approved the demerger of the pharmaceuticals business and simplificatio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters